"Osteoblasts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone.
| Descriptor ID |
D010006
|
| MeSH Number(s) |
A11.329.629
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Osteoblasts".
Below are MeSH descriptors whose meaning is more specific than "Osteoblasts".
This graph shows the total number of publications written about "Osteoblasts" by people in this website by year, and whether "Osteoblasts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 3 | 2 | 5 |
| 1996 | 3 | 0 | 3 |
| 1997 | 3 | 3 | 6 |
| 1998 | 1 | 2 | 3 |
| 1999 | 4 | 0 | 4 |
| 2000 | 2 | 1 | 3 |
| 2001 | 3 | 1 | 4 |
| 2002 | 4 | 1 | 5 |
| 2003 | 4 | 2 | 6 |
| 2004 | 5 | 5 | 10 |
| 2005 | 7 | 6 | 13 |
| 2006 | 4 | 1 | 5 |
| 2007 | 2 | 2 | 4 |
| 2008 | 5 | 7 | 12 |
| 2009 | 6 | 3 | 9 |
| 2010 | 9 | 8 | 17 |
| 2011 | 5 | 5 | 10 |
| 2012 | 7 | 4 | 11 |
| 2013 | 6 | 4 | 10 |
| 2014 | 4 | 6 | 10 |
| 2015 | 6 | 7 | 13 |
| 2016 | 1 | 2 | 3 |
| 2017 | 7 | 4 | 11 |
| 2018 | 2 | 2 | 4 |
| 2019 | 1 | 4 | 5 |
| 2020 | 3 | 3 | 6 |
| 2021 | 1 | 6 | 7 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteoblasts" by people in Profiles.
-
Prostate cancer-induced endothelial-cell-to-osteoblast transition drives immunosuppression in the bone-tumor microenvironment through Wnt pathway-induced M2 macrophage polarization. Proc Natl Acad Sci U S A. 2024 Aug 13; 121(33):e2402903121.
-
Systematic transcriptome profiling of hPSC-derived osteoblasts unveils CORIN's mastery in governing osteogenesis through CEBPD modulation. J Biol Chem. 2024 Aug; 300(8):107494.
-
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect. J Clin Invest. 2024 Jun 17; 134(15).
-
Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo. Acta Biomater. 2024 04 01; 178:83-92.
-
Boosting glycolysis to combat fragile bone in type 1 diabetes. Cell Chem Biol. 2023 09 21; 30(9):1002-1003.
-
Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition. Cancer Res. 2022 09 02; 82(17):3158-3171.
-
Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis. Mol Cancer Ther. 2022 08 02; 21(8):1360-1368.
-
Osteocyte CIITA aggravates osteolytic bone lesions in myeloma. Nat Commun. 2022 06 27; 13(1):3684.
-
4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta. J Bone Miner Res. 2022 04; 37(4):675-686.
-
Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome. PLoS Genet. 2021 12; 17(12):e1009971.